National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Keytruda® for the treatment of unresectable or advanced metastatic melanoma in adults refractory to ipilimumab.

 

Rapid Review

Commenced Completed Outcome
06/08/2015 13/08/2015 Full Pharmacoeconomic Evaluation Recommended

 

Pharmacoeconomic Evaluation

Commenced Completed Outcome
02/11/2015 08/02/2016 Reimbursement Not Recommended

Summary

The HSE has approved reimbursement following confidential price negotiations June 2016.